No positive HIV 1 or HIV 2 test at screening 
no history of significant skin disease such as, but not limited to rash or eruptions, drug allergies, food allergy, dermatitis, eczema, psoriasis, or urticaria 
no history of allergy to drugs such as, but not limited to, sulphonamides and penicillins 
no previously demonstrated clinically significant allergy or hypersensitivity to any of the excipients of the investigational medication administered in this trial 
no female subject of childbearing potential without use of effective nonhormonal birth control methods, or not willing to continue practicing these birth control methods for at least 30 days after the end of the treatment period 
no positive pregnancy test or breast feeding at screening       
    

NCT00752310_exc_T1
Value
positive
NCT00752310_exc_T2
Measurement
HIV 1 test
NCT00752310_exc_T3
Measurement
HIV 2 test
NCT00752310_exc_T4
Temporal
at screening
NCT00752310_exc_T5
Reference_point
screening
NCT00752310_exc_T6
Scope
HIV 1 or HIV 2 test
NCT00752310_exc_T8
Condition
skin disease
NCT00752310_exc_T10
Observation
history
NCT00752310_exc_T11
Qualifier
significant
NCT00752310_exc_T13
Condition
rash
NCT00752310_exc_T14
Condition
eruptions
NCT00752310_exc_T15
Condition
drug allergies
NCT00752310_exc_T16
Condition
food allergy
NCT00752310_exc_T17
Condition
dermatitis
NCT00752310_exc_T18
Condition
eczema
NCT00752310_exc_T19
Condition
psoriasis
NCT00752310_exc_T20
Condition
urticaria
NCT00752310_exc_T21
Scope
rash or eruptions, drug allergies, food allergy, dermatitis, eczema, psoriasis, or urticaria
NCT00752310_exc_T22
Observation
history
NCT00752310_exc_T24
Condition
allergy
NCT00752310_exc_T25
Drug
sulphonamides
NCT00752310_exc_T26
Drug
penicillins
NCT00752310_exc_T27
Scope
sulphonamides and penicillins
NCT00752310_exc_T30
Procedure
pregnancy test
NCT00752310_exc_T31
Value
positive
NCT00752310_exc_T33
Observation
breast feeding
NCT00752310_exc_T34
Temporal
at screening
NCT00752310_exc_T35
Scope
positive pregnancy test or breast feeding
NCT00752310_exc_T29
Temporal
previously
NCT00752310_exc_T36
Qualifier
clinically significant
NCT00752310_exc_T37
Condition
allergy
NCT00752310_exc_T38
Condition
hypersensitivity
NCT00752310_exc_T39
Drug
excipients of the investigational medication
NCT00752310_exc_T40
Scope
allergy or hypersensitivity
NCT00752310_exc_T7
Person
female
NCT00752310_exc_T9
Condition
childbearing potential
NCT00752310_exc_T23
Negation
without
NCT00752310_exc_T28
Qualifier
effective
NCT00752310_exc_T32
Procedure
nonhormonal birth control
NCT00752310_exc_T41
Negation
not
NCT00752310_exc_T42
Mood
willing to continue practicing
NCT00752310_exc_T43
Procedure
birth control methods
NCT00752310_exc_T44
Temporal
for at least 30 days after the end of the treatment period
NCT00752310_exc_T45
Reference_point
the end of the treatment period